2015
DOI: 10.1080/15384101.2015.1053673
|View full text |Cite
|
Sign up to set email alerts
|

Cdk1 plays matchmaker for the Polo-like kinase and its activator SPAT-1/Bora

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 10 publications
(12 citation statements)
references
References 43 publications
(66 reference statements)
0
12
0
Order By: Relevance
“…When mammalian PLK1 is phosphorylated by AKA, mitosis is initiated in the cells [36]. In addition, cyclin B-CDK1-dependent phosphorylation of aurora borealis is a pre-requisite for PLK activation [37]. GlAK was found in basal bodies (in interphase and dividing cells) and mitotic spindles (in dividing cells), and AK inhibition resulted in a cytokinesis defect [23,38,39].…”
Section: Discussionmentioning
confidence: 99%
“…When mammalian PLK1 is phosphorylated by AKA, mitosis is initiated in the cells [36]. In addition, cyclin B-CDK1-dependent phosphorylation of aurora borealis is a pre-requisite for PLK activation [37]. GlAK was found in basal bodies (in interphase and dividing cells) and mitotic spindles (in dividing cells), and AK inhibition resulted in a cytokinesis defect [23,38,39].…”
Section: Discussionmentioning
confidence: 99%
“…(79). In this study, YM-155 mediated a loss of many of these processes including CCNB1 [-2.5, p<0.001] and CCNB2 [-2.77, p<0.001] (which encodes G2/mitotic-specific cyclin-B 1 and 2 proteins) cyclin B/CDK1, BORA, AURKB, CENPA, CCNE2 and its target PLK1 [-2.41, p<0.001], all of which are essential for mitotic recovery after DNA damage (80)(81)(82)(83)(84)(85). Many of these cycle checkpoint transcripts are reportedly overexpressed in aggressive chemo resistant tumors (86)(87)(88)(89)(90)(91) leading to unbridled proliferation (92), poor prognosis (93) to which small-molecule inhibitors that target these kinases are currently being tested as anticancer drugs (94)(95)(96).…”
Section: Discussionmentioning
confidence: 99%
“…During mitotic entry, Polo kinase is activated by phosphorylation of an evolutionarily conserved residue located in the activation loop (Thr210 in human Plk1) [ 29 , 30 ]. Phosphorylation at this residue is primarily mediated by Aurora A in vertebrates ( figure 1 , point 3) [ 31 , 32 ] and possibly also in C. elegans [ 33 , 34 ], and by Aurora B in Drosophila [ 35 ]. Aurora A is enriched at spindle poles, and phosphorylated Plk1 is first detected at centrosomes as human cells enter mitosis [ 10 ].…”
Section: Mechanisms Of Spatio-temporal Regulation Of Polo At the G2/mmentioning
confidence: 99%
“…Bora accumulates at the G2/M transition in human cells and promotes Plk1 phosphorylation by Aurora A [ 31 , 32 ]. Importantly, this function of Bora in Polo activation is greatly stimulated by its phosphorylation by Cyclin–CDK complexes in both human cells and C. elegans [ 33 , 34 , 72 , 73 ]. Cyclin–CDK enzymes phosphorylate Bora at multiple sites but phosphorylation of three evolutionarily conserved residues located in the N-terminal, most conserved part of the protein is critical for Bora function in Polo activation, both in C. elegans embryos and in human cells [ 33 , 72 , 73 ].…”
Section: The Upstream Trigger: Cyclin A–cdk1 Primes Bora For Polo Actmentioning
confidence: 99%